Therapeutics News and Research

RSS

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers investigated the potential anti-COVID-19 activity of traditional Chinese medicine.

25 Aug 2022

Using AI to foster productivity in pharmaceutical research and development

As part of our SLAS Europe 2022 coverage, we speak to Sree Vadlamudi from Iktos, about how we can adopt AI to help foster productivity within pharmaceutical research.

From Society for Laboratory Automation and Screening (SLAS) 25 Aug 2022

The risk of adverse reactions when herbal medications are taken with cancer drugs

A new study discusses phytovigilance initiatives based on the real-world use of herbal drugs in cancer along with conventional chemotherapy.

24 Aug 2022

Study shows how Klebsiella pneumoniae suppresses the body's defenses

New research published in Cell Reports has shown how the bacterium Klebsiella pneumoniae suppresses our body's defences, resulting in it being unable to clear infection.

24 Aug 2022

CRISPR genome-editing technology can be used as a tool to discover RNA therapeutics for lung cancer

An international team of scientists have demonstrated for the first time that CRISPR genome-editing technology can be used as a tool to find new gene therapies for lung cancer.

24 Aug 2022

Recent rise in STIs in the U.S. foreshadows the new monkeypox outbreak

The recent rise in sexually transmitted infections (STIs) in the United States foreshadowed the new monkeypox outbreak.

24 Aug 2022

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

23 Aug 2022

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.

23 Aug 2022

Modified TB vaccine could help treat non-muscle invasive bladder cancer

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.

22 Aug 2022

New combination therapy shows potential to improve survival in children with neuroblastoma

Children who suffer a relapse of the aggressive cancer known as neuroblastoma have small chances of survival.

22 Aug 2022

Consumption of ultra-processed foods increases risk of COVID-19

Researchers explore the association between consumption of ultra-processed foods and risk of SARS-CoV-2 infection.

21 Aug 2022

Non-nutritive sweeteners cause changes in the gut microbes and impact glucose tolerance

Since the late 1800s non-nutritive sweeteners have promised to deliver all the sweetness of sugar with none of the calories.

19 Aug 2022

Day-of-injury blood tests predict which TBI patients are likely to die or survive with severe disability

A study finds that blood tests taken the day of a traumatic brain injury can predict which patients are likely to die or survive with severe disability, allowing clinicians to make decisions earlier on possible treatment of TBI.

19 Aug 2022

Combination of new testing methods helps identify multiple dementia risk genes

A new UCLA-led study has identified multiple new risk genes for Alzheimer's disease and a rare, related brain disorder called progressive supranuclear palsy (PSP) by using a combination of new testing methods allowing for mass screening of genetic variants in a single experiment.

18 Aug 2022

Therapeutic target for several metabolic diseases may help fight Alzheimer’s disease

In the recent popular Korean TV series "The Light in Your Eyes," many viewers emphasized with the main character suffering from Alzheimer's disease.

18 Aug 2022

New study advances the understanding of genetic basis of autism

A new study of genes underlying neurodevelopmental differences has uncovered more than 70 that are very strongly associated with autism and more than 250 with strong links to the condition.

18 Aug 2022

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

A recent article illustrated the derivation and validation of the QCOVID4 risk determination algorithm for predicting COVID-19 hospitalization and death risk in England.

18 Aug 2022

Oral chlorophyllin supplement alleviates inflammatory bowel disease

The dietary supplement chlorophyllin alleviates inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, according to researchers from the Center for Diabetes and Metabolism Research at Sichuan University in China and from Cedars Sinai Medical Center in Los Angeles.

17 Aug 2022

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

New research led by scientists at Mass Eye and Ear and Brigham and Women's Hospital, member hospitals of Mass General Brigham, reveals the role that a genetic variant associated with Alzheimer's disease, APOE4, plays in protecting against glaucoma.

16 Aug 2022

Study finds a declining trend in use of medications for sleep disturbance among Americans

Americans aren't turning to pharmaceutical options as often in the never-ending battle for a good night's sleep.

16 Aug 2022

Therapeutics News and Research

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Using AI to foster productivity in pharmaceutical research and development

The risk of adverse reactions when herbal medications are taken with cancer drugs

Study shows how Klebsiella pneumoniae suppresses the body's defenses

CRISPR genome-editing technology can be used as a tool to discover RNA therapeutics for lung cancer

Recent rise in STIs in the U.S. foreshadows the new monkeypox outbreak

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Modified TB vaccine could help treat non-muscle invasive bladder cancer

New combination therapy shows potential to improve survival in children with neuroblastoma

Consumption of ultra-processed foods increases risk of COVID-19

Non-nutritive sweeteners cause changes in the gut microbes and impact glucose tolerance

Day-of-injury blood tests predict which TBI patients are likely to die or survive with severe disability

Combination of new testing methods helps identify multiple dementia risk genes

Therapeutic target for several metabolic diseases may help fight Alzheimer’s disease

New study advances the understanding of genetic basis of autism

The QCOVID4 algorithm developed using data from the Omicron wave identifies those at highest risk of severe COVID-19 outcomes

Oral chlorophyllin supplement alleviates inflammatory bowel disease

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

Study finds a declining trend in use of medications for sleep disturbance among Americans

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News